Insider Transactions

Kimberly Swan, a director atThe First Bancorp (FNLC), recently picked up 5,000 shares. The buy increased her stake by 249 percent, and came to a total price of just under $151,000. This is the director’s second buy of the year, following a 350 share pickup back in July. Those mark the only two insider buys of 2021. Over the past three years, insiders have been both buyers and sellers, although buyers have far outweighed sales from company insiders, including both directors ...
Read More About This

Damian Novak, Executive Chairman ofFresh Vine Wine Inc (VINE), recently bought 25,200 shares. The buy increased his stake by just under 0.5 percent, and came to a total price of just under $139,000. This marks the first insider transaction at the company since it went public in the past two weeks. Since going public, shares have shed nearly 25 percent of their value. Overall, insiders still own over 77 percent of the company. Shares went public as the company, which focuses on low-calorie ...
Read More About This

Heyward Donigan, President and CEO atRite Aid Corp (RAD), recently bought 14,350 shares. The buy increased his stake by 2.6 percent, and came to a total cost of $200,000. This marks the first insider buy at the company in the past three years. In that timeframe, insiders, including both directors and corporate officers, have been sellers of shares, almost entirely at higher prices than where the stock trades today. Overall, insiders own 2.7 percent of company shares. Shares of the drugstore chain are ...
Read More About This

Matthew Simoncini, a director atLuminar Technology (LAZR), recently added 10,000 shares. The buy increased his holdings by 28 percent, and came to a total cost just over $160,000. This is the second buy from the director in as many weeks, following a 4,355 share buy in mid-December for just under $66,000. A number of other directors and the company CFO have been buyers in the past few weeks. Overall, insiders own 16.7 percent of company shares. The buys have come in as shares ...
Read More About This

Kevin Weil, a President of product and business atPlanet Labs (PL), recently bought 165,580 shares. The buy increased his holdings by over 15 percent, and came to a total purchase price of just over $995,000. This is the second recent buy from insiders, as a company director bought 36,785 shares valued at over $245,000 the week before. These two buys constitute the only insider activity since the company went public. Overall, insiders own about 14 percent of company shares. The company operates one ...
Read More About This

Charles Denson, a director atFunko Inc. (FNKO), recently bought 99,300 shares. The buy increased his stake by over 115 percent, and came to a total purchase price of just over $1.7 million. This marks the first insider buy since August, when a fund with a major ownership stake added to their holdings. Otherwise, company insiders, including both directors and company insiders, have been large sellers of shares. Overall, insiders own about 14 percent of company shares. Insider sellers have been missing out, as ...
Read More About This

Baker Bros Advisors LP, a major holder and director atIncyte Corp (INCY), recently added 1,595,519 shares to their holdings. The buy came to a total purchase price just under $115.6 million, and is a rough doubling of the fund’s holdings in the company. This represents the first insider buy since February, when the company president bought $1 million in company shares. Otherwise, company insiders have generally been regular and steady sellers over the past year. Overall, insiders own about 1.5 percent of ...
Read More About This

Richard Anderson, a director atMedtronic PLC (MDT), recently picked up 5,010 shares. The buy increased his stake by 4.5 percent, and came to a total price just over $517,000. This marks the first insider buy at the company since October 2020. Generally, insiders have been large and consistent sellers of shares, but have found some insider buying when shares have either recently dropped or look poised to move higher. Overall, insiders own a scant 0.2 percent of shares. Shares of the medical device ...
Read More About This